Xiaoli Du
Overview
Explore the profile of Xiaoli Du including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
132
Citations
933
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang L, Xu M, Du X, Qiao L
Psychophysiology
. 2025 Mar;
62(3):e70001.
PMID: 40062564
Resource scarcity has been demonstrated to potentially induce a scarcity mindset in individuals, leading to a reduction in cognitive control. However, the specific facets of cognitive control affected by a...
2.
Liu Y, Chen D, Zhao L, Zhang H, Wu S, Chen X, et al.
Hum Vaccin Immunother
. 2025 Feb;
21(1):2455807.
PMID: 39973250
This study reports on the long-term stability of a recombinant 9-valent HPV vaccine, addressing a gap in the literature as previous research did not extend beyond 72 months. The vaccine...
3.
Li Y, Yu K, Du X, Liu Y, Yan A, Wang M, et al.
China CDC Wkly
. 2025 Feb;
7(4):121-129.
PMID: 39931443
Introduction: is widely distributed in aquatic environments. This study describes the pathogenic characteristics of isolated from adult diarrhea patients and aquatic environments in Beijing, China. Methods: isolates from patients with...
4.
Du X, Jing W, Jiang R, Chen M, Liu D
Water Sci Technol
. 2025 Jan;
91(2):160-173.
PMID: 39882920
Road runoff underwent treatment using a filter filled with sludge from drinking water treatment plants to assess its capacity for removing dissolved organic matter (DOM). This evaluation utilized resin fractionation,...
5.
Du X, Liu F, Jiang R, Tian D, Zheng Z, Sheng H
Environ Geochem Health
. 2024 Dec;
47(1):19.
PMID: 39692917
Road-Deposited Sediments (RDS) samples were collected from four different roads in Beijing, and the distribution of pollutants in RDS with various particle sizes was compared. In this study, the cumulative...
6.
Du X, Tao Q, Fan S, Ren J, Dong Y, Li G, et al.
Drug Dev Ind Pharm
. 2024 Nov;
50(11):952-967.
PMID: 39565140
Background: Wu-Lan Thirteen-Flavour decoction (WLTd), a traditional Mongolian medicine, has been used for treating hypertension in clinical practice, but the chemical basis and underlying mechanisms remain unknown. Methods: The main...
7.
Du X, Zhou J, Zhou Y, Chen Y, Kang Y, Zhao D, et al.
Drug Dev Res
. 2024 Nov;
85(7):e70013.
PMID: 39503161
Polyadenosine diphosphate-ribose polymerase 7 (PARP7) acts as a suppressor of the type I interferon (IFN) signaling pathway via suppressing TANK-binding protein 1 (TBK1). Research study indicates that inhibition of PARP7...
8.
Du X, Barnett C, Widmeyer K, Wang X, Brightman D, Noonan C, et al.
Clin Case Rep
. 2024 Nov;
12(11):e9537.
PMID: 39493792
Recent studies have established an association between variants and Perrault syndrome. In this case report, we present a female patient with Perrault syndrome and cardiomyopathy, resulting from variants in and...
9.
Xiao R, Fu Q, Chen L, Li T, Du X
Ther Drug Monit
. 2024 Jun;
PMID: 38917376
Background: To establish a method for determining the bictegravir (BIC) concentration in human plasma using high-performance liquid chromatography coupled with ultraviolet detection. Methods: The analysis was performed on a CLC-octadecylsilane...
10.
Gao Y, Duan J, Wang C, Yuan Y, Zhang P, Wang Z, et al.
J Med Chem
. 2024 Jun;
67(13):10848-10874.
PMID: 38912753
Bifunctional conjugates targeting PD-L1/PARP7 were designed, synthesized, and evaluated for the first time. Compounds and showed potent activity against PD-1/PD-L1 interaction (IC = 0.426 and 0.342 μM, respectively) and PARP7...